Nevertheless, as we found a general NASH alleviation by HDMCP downregulation, such seesaw effect of HDMCP may slide toward the harmful effect of ATP depletion and targeting HDMCP as a whole controller might be effective in future NASH therapy. This evidence concerns the gene SLC25A47 and metabolic dysfunction-associated steatohepatitis.